Musculoskeletal health in the workplace.


Journal

Best practice & research. Clinical rheumatology
ISSN: 1532-1770
Titre abrégé: Best Pract Res Clin Rheumatol
Pays: Netherlands
ID NLM: 101121149

Informations de publication

Date de publication:
10 2020
Historique:
pubmed: 19 7 2020
medline: 9 3 2021
entrez: 19 7 2020
Statut: ppublish

Résumé

Musculoskeletal (MSK) problems remain the most frequent reason why individuals are absent from work, including those with work-related musculoskeletal disorders (WRMSDs or MSDs) and those with chronic MSK problems. This paper aims to examine changes in work and the workforce since 2000; how work impacts on chronic MSK conditions and how we can help people with these conditions to stay at work. While our knowledge of the causes of WRMSDs has increased since 2000, there has been limited workplace action in reducing exposure to hazards. A life course approach is needed as individuals of all ages are reporting MSK problems. How people work has also changed and informalisation of work contracts has increased with a perceived concurrent reduction in occupational safety and health (OSH) protection. Retaining people at work with MSK problems requires compliance with relevant safety, health and diversity legislation and a risk management approach. Good and open communication within the workplace and identification of other sources of support is also necessary. Considerations must be made at the individual level (internal motivation), organisational level (a supportive manager) and self-management of symptoms. Simple case examples are provided in the paper of what works in practice as well as a proposed research agenda. Increased awareness at all levels of society of MSK health is essential.

Identifiants

pubmed: 32680769
pii: S1521-6942(20)30075-9
doi: 10.1016/j.berh.2020.101558
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101558

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest No other conflicts of interest were reported.

Auteurs

Joanne O Crawford (JO)

Victoria University of Wellington, New Zealand. Electronic address: Joanne.crawford@vuw.ac.nz.

Danielle Berkovic (D)

Monash University, Australia. Electronic address: danielle.berkovic@monash.edu.

Jo Erwin (J)

Bone and Joint Research Group, Royal Cornwall Hospital, UK. Electronic address: josephine.erwin@nhs.net.

Sarah M Copsey (SM)

European Agency for Safety and Health at Work, Spain. Electronic address: copsey@osha.europa.eu.

Alice Davis (A)

Institute of Occupational Medicine, UK. Electronic address: Alice.davis@iom-world.org.

Evanthia Giagloglou (E)

Institute of Occupational Medicine, UK. Electronic address: eva.giagloglou@iom-world.org.

Amin Yazdani (A)

Canadian Institute for Safety, Wellness, and Performance - Conestoga College Institute of Technology and Advanced Learning, Canada. Electronic address: Ayazdani@conestogac.on.ca.

Jan Hartvigsen (J)

University of Southern Denmark, Nordic Institute of Chiropractic and Clinical Biomechanics, Denmark. Electronic address: jhartvigsen@health.sdu.dk.

Richard Graveling (R)

Institute of Occupational Medicine, UK. Electronic address: Richard.graveling@iom-world.org.

Anthony Woolf (A)

Bone and Joint Research Group, Royal Cornwall Hospital, UK. Electronic address: anthony.woolf@btopenworld.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH